Clinical Trials Directory

Trials / Unknown

UnknownNCT04493073

Conjunctival Vascularity Changes Usnig OCTA After Trabeculectomy

Comparison of Conjunctival Vascularity Changes Using Optical Coherence Tomography Angiography After Trabeculectomy With Mitomycin and Ologen Implants

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Asmaa Ahmed Ali Youssif · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

* Reduce the trauma and the time taken for patient rehabilitation. * The prevailing trend is to perform a mitomycin- C (MMC)-augmented trabeculectomy and trabeculectomy with ologen implants in a trial to decrease bleb failure as a common post- trabeculectomy complication. * Is to develop a measurement protocol by OCT-A imaging and characterization of the bleb vascularity changes in glaucoma patients before and after surgery.

Detailed description

The main purpose of this project is to compare bleb vascularity changes using optical coherence tomography (OCT-A) between mitomycin- C (MMC)-augmented trabeculectomy and develop trabeculectomy with ologen implants to determine whether bleb vascularity measurements during preoperative and early postoperative periode could act as surrogate parameters to predict surgical outcomes. Glaucoma often existent in the elderly population. Measuremets of bleb vascularity beginning to become an essential part of the glaucoma specialist's clinical and operative took. As investigators continue to collect data both clinically and in the laboratory, these various imaging modalities will shepherd surgeons into a more precise and predicable era of glaucoma surgeries.

Conditions

Interventions

TypeNameDescription
PROCEDURETrabectulectomydecrease IOP
DRUGMitomycinDecrease bleb failure
DEVICEOlogen Collagen ImplantOlogen Collagen Implant (Aeon Astron Europe, Netherlands)
DEVICEMitomycin-C Kyowa®Mitomycin-C Kyowa® (Biochem Pharmaceutical Industries, India)

Timeline

Start date
2020-12-01
Primary completion
2021-12-01
Completion
2022-03-01
First posted
2020-07-30
Last updated
2020-07-30

Source: ClinicalTrials.gov record NCT04493073. Inclusion in this directory is not an endorsement.